Cite Filings / CVKD / 0001213900-23-004435
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B4

Prospectus

Cadrenal Therapeutics, Inc. · Filed 2023-01-23 · Acc 0001213900-23-004435

Documents 1

  • 424B4 Prospectus , f424b40123_cadrenalprosb.htm

Around this filing

  • 2023-01-25 8-K Material agreement · Unregistered share sale · Executive or director change · Other events
  • 2023-01-24 4 Director acquired 50,000 shares (conversion)
  • 2023-01-24 4 Chief Financial Officer acquired 50,000 shares (grant or award)
  • 2023-01-24 4 Director acquired 514,792 shares (conversion)
  • 2023-01-24 S-8 Securities Offered to Employees in Benefit Plans
  • 2023-01-23 424B4 Prospectus
  • 2023-01-23 424B4 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading f424b40123_cadrenalprosb.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…